Vanguard Group Inc Biolife Solutions Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,804,140 shares of BLFS stock, worth $60.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,804,140
Previous 2,836,257
1.13%
Holding current value
$60.3 Million
Previous $73.6 Million
13.02%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BLFS
# of Institutions
202Shares Held
48.8MCall Options Held
2.5KPut Options Held
182K-
Casdin Capital, LLC New York, NY8.71MShares$187 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$118 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$76.3 Million0.02% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$33 Million0.21% of portfolio
-
State Street Corp Boston, MA1.43MShares$30.8 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $918M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...